Researchers should keep close tabs on clinical trial participants completing outpatient patient-reported outcome measurements in order to avoid missing data, the US Food and Drug Administration says.
New guidance issued 14 September by the FDA centers for drug and biologics evaluation and research outlines recommendations for...







